scorecardresearch
Business Today
Subscribe
Immersives UPSTART G20 Summit Corporate Petrol-Diesel Weather BT Bazaar
BT 100 BT Accenture PwC De-risking the Future BT-TR GCC Listing
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
News
Markets
Stocks
Aarti Drugs Ltd

Feedback
Aarti Drugs Ltd

Aarti Drugs Ltd (AARTIDRUGS) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 220,954
Sep 14, 2023 15:58 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹605.60
₹7.80 (1.30%)
₹598 Low
Today’s Performance
₹614.45 High
₹313.9 Low
52 Week’s Performance
₹645.75 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day 1.30%
  • 1 Week -1.94%
  • 1 Month 7.79%
  • 3 Months 33.23%
  • 6 Months 84.94%
  • 1 Year 32.14%
  • 3 Years -6.13%
  • 5 Years 30.48%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 0.32
  • 52-Week Low (₹) 313.90
  • 52-Week High (₹) 645.75
  • Price-to-Book (X)* 4.70
  • Dividend Yield (%) 0.17
  • Price-to-Earnings (P/E) (X)* 31.27
  • Earnings Per Share (₹) 19.37
  • Sector Price Earning (X)* 33.20
  • Market Cap (₹ Cr.)* 5,607.86
  • * Vaues as of last close price

COMPETITORS

BT TV

thumb 39:53 Historic India-Middle East-Europe Corridor Puts China On Notice
THUMB 5:05 Delhi Tops In Terms Of Electric Buses After Arvind Kejriwal Govt Introduces 400 New Buses
thumb 4:42 The India-Middle East-Europe Corridor: A Counter To China's Belt & Road Initiative
THUMB 4:04 Putin Praises Modi’s ‘Make In India’, Cites Example To Russian Auto Industry
THUMB 9:44 Tata Motors' Electrifying Future: In Conversation With Shailesh Chandra On EV Expansion
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

No Data For Block Deal.

*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Jul 25, 2023 PURCHASE
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 933060
  • Average Price ₹627.89
Jul 25, 2023 Sell
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 933060
  • Average Price ₹628.40
Jul 24, 2023 Sell
Aarti Drugs Ltd. ,QE SECURITIES
  • Qty 505851
  • Average Price ₹587.73
Jul 24, 2023 Sell
Aarti Drugs Ltd. ,NK SECURITIES RESEARCH PRIVATE LIMITED
  • Qty 553535
  • Average Price ₹588.59
Jul 24, 2023 PURCHASE
Aarti Drugs Ltd. ,NK SECURITIES RESEARCH PRIVATE LIMITED
  • Qty 553535
  • Average Price ₹588.25
Jul 24, 2023 Sell
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 643754
  • Average Price ₹576.46
Jul 24, 2023 PURCHASE
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 643754
  • Average Price ₹575.88
Jul 24, 2023 PURCHASE
Aarti Drugs Ltd. ,QE SECURITIES
  • Qty 497273
  • Average Price ₹587.77
Mar 24, 2023 Sell
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 723086
  • Average Price ₹395.54
Mar 24, 2023 PURCHASE
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 723086
  • Average Price ₹395.14
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

FAQ’S

What was Aarti Drugs Ltd share price previously?
Aarti Drugs Ltd share price was up by 1.30% from the previous closing price of ₹597.80.
Who are peers of Aarti Drugs Ltd?
The peers of Aarti Drugs Ltd are Sun Pharmaceuticals Industries Ltd, Lupin Ltd, Torrent Pharmaceuticals Ltd, Aurobindo Pharma Ltd, Zydus Lifesciences Ltd, Cipla Ltd, Glenmark Pharmaceuticals Ltd, Glaxosmithkline Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Biocon Ltd, Alkem Laboratories Ltd, Gland Pharma Ltd, Syngene International Ltd, Divis Laboratories Ltd.
Who is/are the promoter/promoters of Aarti Drugs Ltd?
The promotor/promotors of Aarti Drugs Ltd are Prakash M Patil, Rashesh C Gogri, Harshit M Savla, Harit P Shah, Uday M Patil, Narendra Jagannath Salvi, Navin Chapshi Shah, Krishnacharya G Akamanchi, Priti Savla, Ankit Vikram Paleja, Bhaskar Narayan Thorat, Neha Gada.
What has been 52-week high of Aarti Drugs Ltd stocks?
The highest price of Aarti Drugs Ltd stock is ₹645.75 in the last 52-week.
What is the share price of Aarti Drugs Ltd (AARTIDRUGS) today on NSE?
As on Sep 14, 2023, Aarti Drugs Ltd (AARTIDRUGS)’s share price on NSE is Rs 605.6
What is the market cap of Aarti Drugs Ltd (AARTIDRUGS?)
The current market capitalisation of Aarti Drugs Ltd (AARTIDRUGS) is 5,607.86 crores
What is Aarti Drugs Ltd Share symbol?
The symbol of Aarti Drugs Ltd is AARTIDRUGS.
What is the PE ratio of Aarti Drugs Ltd (AARTIDRUGS)?
The current PE ratio of Aarti Drugs Ltd (AARTIDRUGS) is 31.27.
What is the PB ratio of Aarti Drugs Ltd (AARTIDRUGS)?
The current PB ratio of Aarti Drugs Ltd (AARTIDRUGS) is 4.70.
Today’s High & Low share prices of Aarti Drugs Ltd (AARTIDRUGS) on NSE?
Today, the share price of Aarti Drugs Ltd (AARTIDRUGS) on NSE touched a high of Rs 614.45 and a low of Rs 598
What price did Aarti Drugs Ltd (AARTIDRUGS) shares open on the NSE today?
On NSE, the share price of Aarti Drugs Ltd (AARTIDRUGS) opened at Rs 603.6
What is the 52-week high of Aarti Drugs Ltd (AARTIDRUGS)?
The 52-week high price of Aarti Drugs Ltd (AARTIDRUGS) is Rs 645.75
What is the 52-week low of Aarti Drugs Ltd (AARTIDRUGS) ?
The 52-week low price of Aarti Drugs Ltd (AARTIDRUGS) is Rs 313.9

ABOUT AARTI DRUGS

Aarti Drugs Ltd, incorporated in the year 1984, has its registered office in Plot No N-198 MIDC Tarapur, Pamtembhi Village Palghar Tal, Thane, Maharashtra, 401506, 91-22-24072249, 91-22-24073462/24070144. The main industry in which Aarti Drugs Ltd operates is Pharmaceuticals - Indian - Bulk Drugs.

Auditor/Auditors for Aarti Drugs Ltd is/are Kirtane & Pandit LLP. In the main management, Prakash M Patil is chairman and is the company secretary for Aarti Drugs Ltd.

  • PMP Prakash M Patil CMD & Executive Director
  • RCG Rashesh C Gogri ED / MD / Promoter
  • HMS Harshit M Savla ED / Joint MD / Promoter
  • HPS Harit P Shah E D & Wholetime Director
  • UMP Uday M Patil WTD & Executive Director
  • NJS Narendra Jagannath Salvi Non Executive Director
  • NCS Navin Chapshi Shah Independent Non Exe. Director
  • KGA Krishnacharya G Akamanchi Independent Non Exe. Director
  • PS Priti Savla Independent Non Exe. Director
  • AVP Ankit Vikram Paleja Independent Non Exe. Director
  • BNT Bhaskar Narayan Thorat Independent Non Exe. Director
  • NG Neha Gada Independent Non Exe. Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.